-+ 0.00%
-+ 0.00%
-+ 0.00%

STRUCTURE THERAPEUTICS - ALENIGLIPRON DEMONSTRATES 10.4% DISCONTINUATION RATE WITH FAVORABLE TOLERABILITY

Reuters·06/05/2026 20:17:41

Please log in to view news